Key result
Lean Six Sigma increases IV-tPA administration ~15% while cutting acute stroke process times.
Answers are grounded in this paper and cite their sources.
Case study demonstrates reduced treatment lead times and higher thrombolysis rates in acute stroke care, indicating the value of Lean Six Sigma workflows in rural hospitals.
PURPOSE: This case study aims to demonstrate the strengths of the Lean Six Sigma (LSS) methodology to improve the acute ischemic stroke (AIS) treatment rates and reduce process lead time at Baruch Padeh Medical Center (BPMC), a rural hospital in the Galilee region of Northern Israel. The LSS project redefined the BPMC stroke care pathway and increased its efficacy. DESIGN/METHODOLOGY/APPROACH: The LSS methodology was implemented in September 2017 by integrating lean principles and the Six Sigma DMAIC (Define-Measure-Analyze-Improve-Control). Existing procedures, field observation, ad hoc measurement and in-depth interviews were utilized, and the GEMBA method was implemented to identify root cause and improve actions optimizing the stroke pathway. FINDINGS: The presented case shows the usefulness of the LSS methodology in improving quality performance in a rural hospital. The intervention allowed the BPMC to improve the intravenous tissue plasminogen activator (IV-tPA) administration rate (+15.2%), reducing the process lead time. The lead time of door-to-computer tomography decreased from 52 to 26 min, and the door-to-needle time decreased from 94 to 75 min. ORIGINALITY/VALUE: The present case study shows the implementation of the LSS methodology aimed to improve the IV-tPA administration rate and reduce the stroke pathway lead time in a rural hospital. The case demonstrates the potential for the LSS methodology to support the AIS pathway optimization and represents a guide for healthcare organizations located in rural areas.
No takes yet. Share an insight, caveat, or question.
A 2022 study studied Acute ischemic stroke. Lean Six Sigma (LSS) methodology (DMAIC and GEMBA) vs. Pre-intervention existing stroke care pathway was evaluated on Intravenous tissue plasminogen activator (IV-tPA) administration rate and process lead times (door-to-CT and door-to-needle times). Lean Six Sigma implementation increased IV-tPA administration by 15.2%, reducing door-to-CT time from 52 to 26 min and door-to-needle time from 94 to 75 min.
Synapse has enriched 10 related papers. Consider them for comparative context: